KLK3 and prostate cancer: The 3.4 kb mitochondrial DNA deletion measured in blood plasma accurately predicts CS prostate cancer and correlates well to both image-guided biopsy outcome in a repeat biopsy setting as well as prostatectomy outcome in a first biopsy setting for men in the PSA ‘grey zone’.